Maxigen Biotech Inc. (MBI) was formed by a group of entrepreneurs and scientists in December 1998. With headquarters in Taipei, Taiwan, MBI has utilized its core competence in biopolymers and developed a broad range of applications in areas such as medical devices and skincare products. MBI specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. Our major shareholders include GIH Group, Mega International Commercial Bank, First Financial H... More